Intellectual Property Cases filed in the US District Court for the Eastern District of Pennsylvania
Cases 1 - 10 of 18
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. QILU PHARMA INC.
as 2:2021cv00564
Plaintiff: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant: Qila Pharma Inc. and QILU PHARMA INC.
Cause Of Action: 35 U.S.C. § 271
BOEHRINGER INGELHEIM PHARMACEUTICALS INC. et al v. HEC PHARM CO., LTD. et al
as 2:2020cv02545
Plaintiff: BOEHRINGER INGELHEIM CORPORATION, BOEHRINGER INGELHEIM INTERNATIONAL GMBH, BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG and others
Defendant: HEC PHARM USA and HEC PHARM CO., LTD.
Cause Of Action: 35 U.S.C. § 271
MYLAN PHARMACEUTICALS INC. v. JANSSEN PHARMACEUTICALS, INC.
as 2:2015cv02990
Plaintiff: MYLAN PHARMACEUTICALS INC.
Defendant: JANSSEN PHARMACEUTICALS, INC.
Cause Of Action: 28 U.S.C. § 2201
PAR PHARMACEUTICAL, INC. v. GLAXOSMITHKLINE LLC et al
as 2:2014cv06627
Plaintiff: PAR PHARMACEUTICAL, INC.
Defendant: GLAXOSMITHKLINE LLC , APTALIS PHARMA US, INC. , APTALIS PHARMATECH, INC. and others
Cause Of Action: 15 U.S.C. § 1126
BRAINTREE LABORATORIES, INC. v. GATOR PHARMACEUTICALS, INC. et al
as 2:2013cv01975
Plaintiff: BRAINTREE LABORATORIES, INC.
Defendant: GATOR PHARMACEUTICALS, INC. and KVK-TECH, INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
LUPIN ATLANTIS HOLDINGS S.A. v. MYLAN INC. et al
as 2:2011cv03129
Plaintiff: LUPIN ATLANTIS HOLDINGS S.A.
Defendant: MYLAN INC. , MYLAN PHARMACEUTICALS, INC. and ETHYPHARM S.A.
Counter_claimant: MYLAN PHARMACEUTICALS, INC. and MYLAN INC.
Counter_defendant: LUPIN ATLANTIS HOLDINGS S.A.
Cause Of Action: 35 U.S.C. § 271
LUPIN ATLANTIS HOLDINGS S.A. v. RANBAXY LABORATORIES LIMITED et al
as 2:2011cv02295
Plaintiff: LUPIN ATLANTIS HOLDINGS S.A.
Defendant: RANBAXY LABORATORIES LIMITED, RANBAXY PHARMACEUTICALS INC., RANBAXY, INC. and others
Cause Of Action: 35 U.S.C. § 271
PAR PHARMACEUTICAL, INC. v. UCB, INC. et al
as 2:2011cv02010
Plaintiff: PAR PHARMACEUTICAL, INC.
Defendant: UCB, INC. and UCB PHARMA S.A.
Cause Of Action: 35 U.S.C. § 145
LUPIN ATLANTIS HOLDINGS S.A. v. MYLAN INC. et al
as 2:2011cv01930
Plaintiff: LUPIN ATLANTIS HOLDINGS S.A.
Defendant: MYLAN INC. , MYLAN PHARMACEUTICALS, INC. and ETHYPHARM S.A.
Counter_claimant: MYLAN PHARMACEUTICALS, INC. and MYLAN INC.
Counter_defendant: LUPIN ATLANTIS HOLDINGS S.A.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
LUPIN ATLANTIS HOLDINGS S.A. v. RANBAXY LABORATORIES LIMITED et al We have downloadable decisions or orders for this case
as 2:2010cv03897
Plaintiff: LUPIN ATLANTIS HOLDINGS S.A.
Defendant: RANBAXY LABORATORIES LIMITED, RANBAXY PHARMACEUTICALS INC., RANBAXY, INC. and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?